462 related articles for article (PubMed ID: 15663664)
1. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.
Kanwar AJ; Dogra S; Parsad D; Kumar B
Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664
[TBL] [Abstract][Full Text] [Related]
2. Narrow-band UVB for the treatment of generalized vitiligo in children.
Kanwar AJ; Dogra S
Clin Exp Dermatol; 2005 Jul; 30(4):332-6. PubMed ID: 15953060
[TBL] [Abstract][Full Text] [Related]
3. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
4. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy.
Njoo MD; Bos JD; Westerhof W
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):245-53. PubMed ID: 10642680
[TBL] [Abstract][Full Text] [Related]
5. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
[TBL] [Abstract][Full Text] [Related]
6. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
Parsad D; Kanwar AJ; Kumar B
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
[TBL] [Abstract][Full Text] [Related]
7. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
8. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
[TBL] [Abstract][Full Text] [Related]
9. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
[TBL] [Abstract][Full Text] [Related]
10. Narrowband UVB therapy for vitiligo: does the repigmentation last?
Sitek JC; Loeb M; Ronnevig JR
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):891-6. PubMed ID: 17658996
[TBL] [Abstract][Full Text] [Related]
11. Long-term results in the treatment of vitiligo with oral khellin plus UVA.
Hofer A; Kerl H; Wolf P
Eur J Dermatol; 2001; 11(3):225-9. PubMed ID: 11358729
[TBL] [Abstract][Full Text] [Related]
12. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients.
Fai D; Cassano N; Vena GA
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):916-20. PubMed ID: 17659000
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites.
Anbar TS; Westerhof W; Abdel-Rahman AT; El-Khayyat MA
Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):157-63. PubMed ID: 16719871
[TBL] [Abstract][Full Text] [Related]
14. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
[TBL] [Abstract][Full Text] [Related]
15. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
16. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
[TBL] [Abstract][Full Text] [Related]
17. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
Kullavanijaya P; Lim HW
Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
[TBL] [Abstract][Full Text] [Related]
18. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
Chimento SM; Newland M; Ricotti C; Nistico S; Romanelli P
J Drugs Dermatol; 2008 Mar; 7(3):258-63. PubMed ID: 18380207
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
20. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
Lahiri K; Malakar S; Sarma N; Banerjee U
Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]